Search research articles
Contact Us
Filters
Showing results (121-130 of 138) with videos related to
Page
of 14
Sort By:
Neural Development
|
September 13, 2012
Ultrabithorax confers spatial identity in a context-specific manner in the Drosophila postembryonic ventral nervous system
Elizabeth C Marin, Katie E Dry, Danielle R Alaimo, et al.
Antimicrobial Agents and Chemotherapy
|
October 21, 2009
MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease
Nigel J Liverton, Steven S Carroll, Jillian Dimuzio, et al.
Angewandte Chemie (International Ed. in English)
|
October 18, 2008
Bismacrocyclic inhibitors of hepatitis C NS3/4a protease
John A McCauley, Michael T Rudd, Kevin T Nguyen, et al.
Journal of the American Chemical Society
|
March 15, 2008
Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease
Nigel J Liverton, M Katharine Holloway, John A McCauley, et al.
Nature Communications
|
February 6, 2021
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
Chuan Hong, Noel J Byrne, Beata Zamlynny, et al.
Nature
|
April 6, 2017
Structural basis for selectivity and diversity in angiotensin II receptors
Haitao Zhang, Gye Won Han, Alexander Batyuk, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure
Michael T Rudd, John A McCauley, John W Butcher, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2012
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants
Vincenzo Summa, Steven W Ludmerer, John A McCauley, et al.
Journal of Medicinal Chemistry
|
June 11, 2014
Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic pain
Shawn J Stachel, John M Sanders, Darrell A Henze, et al.
Journal of Medicinal Chemistry
|
February 19, 2010
Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor
John A McCauley, Charles J McIntyre, Michael T Rudd, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 138) with videos related to
Sort By:
Page
of 14
Neural Development
|
September 13, 2012
Ultrabithorax confers spatial identity in a context-specific manner in the Drosophila postembryonic ventral nervous system
Elizabeth C Marin, Katie E Dry, Danielle R Alaimo, et al.
Antimicrobial Agents and Chemotherapy
|
October 21, 2009
MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease
Nigel J Liverton, Steven S Carroll, Jillian Dimuzio, et al.
Angewandte Chemie (International Ed. in English)
|
October 18, 2008
Bismacrocyclic inhibitors of hepatitis C NS3/4a protease
John A McCauley, Michael T Rudd, Kevin T Nguyen, et al.
Journal of the American Chemical Society
|
March 15, 2008
Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease
Nigel J Liverton, M Katharine Holloway, John A McCauley, et al.
Nature Communications
|
February 6, 2021
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
Chuan Hong, Noel J Byrne, Beata Zamlynny, et al.
Nature
|
April 6, 2017
Structural basis for selectivity and diversity in angiotensin II receptors
Haitao Zhang, Gye Won Han, Alexander Batyuk, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure
Michael T Rudd, John A McCauley, John W Butcher, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2012
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants
Vincenzo Summa, Steven W Ludmerer, John A McCauley, et al.
Journal of Medicinal Chemistry
|
June 11, 2014
Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic pain
Shawn J Stachel, John M Sanders, Darrell A Henze, et al.
Journal of Medicinal Chemistry
|
February 19, 2010
Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor
John A McCauley, Charles J McIntyre, Michael T Rudd, et al.
Page
of 14